# Thermo Fisher invests $25M in sterile injectables facility in Monza, Italy

Thermo Fisher's Pharma Services announced a $25 million investment in its Monza, Italy site to establish sterile injectables development capabilities. The 2,300 m² facility is expected to be fully operational in the second half of 2019.

- Type: Expansion
- Announced: 2018-06-26
- Where: Monza, Italy, Italy
- Value: $25.0M
- Starts operating: Q3 2019
- Status: under construction
- Products: sterile injectables
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Thermo Fisher Scientific](https://endata.com/companies/7061.md)

## Sources

- [bioprocessonline.com](https://www.bioprocessonline.com/doc/thermo-fisher-continues-to-expand-sterile-injectables-development-capabilities-in-monza-italy-0001), 2018-06-26: "Thermo Fisher’s Pharma Services announced the $25 million investment in its Monza, Italy site to establish state-of-the-art development capabilities."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.